Overview
Atrial Fibrillation
Cancer Associated Thrombosis
The Promise of Factor XI
Abelacimab: A Novel Anticoagulant
Clinical Development Program
Our Mission
Our Team
Milestones & Achievements
Patient Advocacy
Healthcare Professionals
Fierce Biotech
https://www.fiercebiotech.com/biotech/blackstone-novartis-found-cardiovascular-startup-250m
